|
Trial of a new malaria vaccine on both humans a mice has been successful and could help eradicate the disease that causes atleast one million deaths annually, researchers say. Pierre Druilhe and his team at Pasteur Institute here injected an MSP-3 based vaccine into 30 European volunteers who never had malaria,re-administering it after one month and again after four months, the online Edition of Scientific American reported. Blood samples were taken one month after each injection. These blood samples were then compared to blood samples from people in France who had no immunity to malaria and blood samples from African people with immunity. Nearly every vaccinated sample produced an immune response to malaria when it was produced in vitro and 77% produced anti-MSP -3 antibodies. These antibodies proved to be as good at killing the parasite as those kill from immune adults and, in some cases, better. |
|
|
|
|
| Posted : 11/12/2005 |
|
|
|
|
